BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27780320)

  • 1. Early Nonresponse in the Antipsychotic Treatment of Acute Mania: A Criterion for Reconsidering Treatment? Results From an Individual Patient Data Meta-Analysis.
    Welten CC; Koeter MW; Wohlfarth TD; Storosum JG; van den Brink W; Gispen-de Wied CC; Leufkens HG; Denys DA
    J Clin Psychiatry; 2016 Sep; 77(9):e1117-e1123. PubMed ID: 27780320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial.
    Xiao L; Ganocy SJ; Findling RL; Chang K; DelBello MP; Kane JM; Tohen M; Xiang YT; Correll CU
    J Clin Psychiatry; 2017; 78(9):e1158-e1166. PubMed ID: 28922591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo response in antipsychotic trials of patients with acute mania: Results of an individual patient data meta-analysis.
    Welten CC; Koeter MW; Wohlfarth T; Storosum JG; van den Brink W; Gispen-de Wied CC; Leufkens HG; Denys DA
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1018-26. PubMed ID: 25907248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder.
    Weiser M; Burshtein S; Gershon AA; Marian G; Vlad N; Grecu IG; Tocari E; Tiugan A; Hotineanu M; Davis JM
    Bipolar Disord; 2014 Jun; 16(4):441-7. PubMed ID: 24712840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial.
    Pagsberg AK; Krogmann A; Jeppesen P; von Hardenberg L; Klauber DG; Jensen KG; Rudå D; Decara MS; Jepsen JRM; Fagerlund B; Fink-Jensen A; Correll CU; Galling B
    J Am Acad Child Adolesc Psychiatry; 2022 Aug; 61(8):997-1009. PubMed ID: 35026408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Insight Affect the Efficacy of Antipsychotics in Acute Mania?: An Individual Patient Data Regression Meta-Analysis.
    Welten CC; Koeter MW; Wohlfarth TD; Storosum JG; van den Brink W; Gispen-de Wied CC; Leufkens HG; Denys DA
    J Clin Psychopharmacol; 2016 Feb; 36(1):71-6. PubMed ID: 26647231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials.
    Samara MT; Nikolakopoulou A; Salanti G; Leucht S
    Schizophr Bull; 2019 Apr; 45(3):639-646. PubMed ID: 29982701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
    J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study.
    Khanna S; Vieta E; Lyons B; Grossman F; Eerdekens M; Kramer M
    Br J Psychiatry; 2005 Sep; 187():229-34. PubMed ID: 16135859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of drug treatment for acute mania differs across geographic regions: An individual patient data meta-analysis of placebo-controlled studies.
    Welten CC; Koeter MW; Wohlfarth TD; Storosum JG; van den Brink W; Gispen-de Wied CC; Leufkens HG; Denys DA
    J Psychopharmacol; 2015 Aug; 29(8):923-32. PubMed ID: 26038109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies.
    Samara MT; Goldberg Y; Levine SZ; Furukawa TA; Geddes JR; Cipriani A; Davis JM; Leucht S
    Lancet Psychiatry; 2017 Nov; 4(11):859-867. PubMed ID: 28939419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    Ketter TA; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
    Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B
    J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.